Developing Strategies to Optimize the Exercise Response After Tetraplegia.
NCT ID: NCT04465825
Last Updated: 2021-05-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
16 participants
INTERVENTIONAL
2021-06-30
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Finding the Optimal Voluntary Exercise Parameters for Those Living With Quadriplegia
NCT03146728
Effects of Exercise in People With Tetraplegia
NCT01202019
Resistance Training to Improve Strength and Functional Trunk Stability in Adults With Paraplegia
NCT03949699
Cardiovascular Effects of High Intensity Interval Training in Individuals With Paraplegia
NCT04378218
Nerve Transfer to Improve Function in High Level Tetraplegia
NCT06288763
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will have their peak energy expenditure measured using a discontinuous step test. Participants will then perform three different trials of exercise at a steady state at a target intensity that corresponds with 90%, 70%, and 60% of their own measured peak energy expense. Participants will exercise at the prescribed power output until fatigue. Participants may choose which exercise mode they use (with all steady-state trials being in the same mode as the peak test), and may choose to perform the study twice in the different exercise modes. Exercise trials will be performed over a number of different sessions in a randomized order, allowing for adequate rest and recovery between trials, and depending on each participant's capabilities and preferences.
Part II. This study will determine if high intensity interval training (HIIT) results in greater energy expense than constant rate aerobic exercise, and will test if exercising with HITT effects time to fatigue.
Participants will exercise using a high intensity interval training (HIIT) protocol, which involves alternating high intensity bouts of short duration with low intensity bouts of longer duration. Participants will have their peak energy expenditure measured using a discontinuous step test. Participants will then perform one trial of steady-state exercise at a target intensity that corresponds with 50% of their peak energy expense, for a target of 20-45 minutes. Participants will perform a separate trial using a HIIT protocol of exercise at a target intensity that corresponds with 50% of their peak energy expense interspersed with bouts of high intensity (target intensity that corresponds with 90% of peak energy expense) for 30-60 seconds, for a total duration target of 20-45 minutes.
Participants may choose which exercise mode they use (with all trials being in the same mode as the peak test), and may choose to perform the study twice in the different exercise modes. Exercise trials will be performed over a number of different sessions in a randomized order, allowing for adequate rest and recovery between trials, and depending on each participant's capabilities and preferences.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interspersing HITT in exercise
We will test whether introducing HITT into an acute exercise bout will increase overall energy expenditure or time to fatigue.
HITT: intermittent high intensity exercise
Intermittent bouts of 30-60 seconds of exercise at 90% of peak intensity (HITT).
Acute exercise bout with no HITT
Exercise will occur at 50% peak without introducing HITT.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HITT: intermittent high intensity exercise
Intermittent bouts of 30-60 seconds of exercise at 90% of peak intensity (HITT).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18-75 years for the duration of the study participation
* Medically stable and healthy enough to engage in and complete exercise requirements
* Willing and able to complete the exercise protocols and testing requirements
* Able to understand and follow written and verbal instructions from study staff
* Able to communicate with study staff about their exercise capabilities and preferences
Exclusion Criteria
* Known cardiovascular disease
* Unsatisfactory results of EKG screening
* Implanted electronic cardiac device (e.g. pace maker, defibrillator, etc.)
* Current pressure ulcer(s)
* Morbid obesity
* Known thyroid dysfunction
* Current cancer
* Current uncontrolled high blood pressure ( \> 140/90 mmHg)
* Uncontrolled epilepsy
* Current deep vein thrombosis
* Ventilator-dependent
* Cognitive impairment
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Manitoba
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HS22987
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.